Researchers have identified a biomarker in spinal fluid that can detect Parkinson’s disease in its early stages with over 90% accuracy.
UIC engineers fuse hydrogen and nitrogen for the first time, offering cleaner energy options—but the process carries major environmental and economic risks.
As humanity prepares to return to the moon, scientists also have ideas for huge lunar experiments that could revolutionise astrophysics
In this remarkable conversation, Michael Levin (Tufts University) and Blaise Agüera y Arcas (Google) examine what happens when biology and computation collide at their foundations. Their recent papers—arriving simultaneously yet from distinct intellectual traditions—illuminate how simple rules generate complex behaviors that challenge our understanding of life, intelligence, and agency.
Michael’s \
This is an interview with Dr. Michael Levin, a pioneering developmental biologist at Tufts University.
This is an additional installment of our \.
Main episode with Michael Levin (June 2024): https://youtu.be/c8iFtaltX-s?list=PLZ7ikzmc6zlN6E8KrxcYCWQIHg2tfkqvR
Listen on Spotify: https://open.spotify.com/show/4gL14b92xAErofYQA7bU4e.
Become a YouTube Member Here:
https://www.youtube.com/channel/UCdWIQh9DGG6uhJk8eyIFl1w/join.
Join TOEmail at https://www.curtjaimungal.org.
Support TOE:
- Patreon: https://patreon.com/curtjaimungal (early access to ad-free audio episodes!)
- Crypto: https://tinyurl.com/cryptoTOE
- PayPal: https://tinyurl.com/paypalTOE
- TOE Merch: https://tinyurl.com/TOEmerch.
Vitamin D supplements may help decrease the risk of colorectal cancer and improve survival for people with colorectal cancer, a literature review of 50 studies has found.
For decades, researchers have been exploring ways to harness the power of the immune system to treat cancer. One breakthrough is cell therapy, often called ‘living drugs.’ This is a form of immunotherapy that uses immune cells from a patient or a healthy donor. With advanced engineering techniques, scientists enhance these cells to recognize better and attack cancer.
“During the late 1980s and 1990s, cancer researchers started exploring ways to advance immunotherapy by transferring immune cells into a patient to attack cancer cells,” says stem cell transplant and cellular therapy specialist Hind Rafei, M.D. “They recognized that immune cells found inside tumors could help destroy cancer cells, leading to the development of one of the earliest forms of cell therapy — tumor-infiltrating lymphocytes (TILs).”
Cell therapy is a form of immunotherapy that uses immune cells from a patient or a healthy donor to treat cancer. Learn about the types of cell therapy from stem cell transplant and cellular therapy specialist Hind Rafei, M.D.
A new study from researchers at Moffitt Cancer Center shows that blocking a chemical process called nitrosylation could make one of the most aggressive forms of melanoma more treatable.
We use cookies to make sure that our website works properly, as well as some optional cookies to personalise content and advertising, provide social media features and analyse how people use our site. By accepting some or all optional cookies you give consent to the processing of your personal data, including transfer to third parties, some in countries outside of the European Economic Area that do not offer the same data protection standards as the country where you live. You can decide which optional cookies to accept by clicking on “Manage preferences”, where you can also find more information about how your personal data is processed. Further information can be found in our privacy policy.